Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1613
This examiner grants 15% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17892353 | ORAL CARE COMPOSITIONS FOR GUM HEALTH | Final Rejection | The Procter & Gamble Company |
| 17892387 | ORAL CARE COMPOSITIONS FOR GUM HEALTH | Final Rejection | The Procter & Gamble Company |
| 17926105 | FORUMULATION OF MONODISPERSE KINETICALLY FROZEN POLYMER MICELLES VIA EQUILIBRATION-NANOPRECIPITATION | Final Rejection | Purdue Research Foundation |
| 18031669 | MODIFIED RELEASE SOFTGEL CAPSULES | Non-Final OA | R.P. SCHERER TECHNOLOGIES, LLC |
| 17907603 | PRECISION DELIVERY OF MULTI-SCALE PAYLOADS TO TISSUE-SPECIFIC TARGETS IN PLANTS | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18250260 | OPEN CELL HYDROGEL NETWORKS AND METHODS FOR MAKING AND USING THE SAME | Final Rejection | University of Florida Research Foundation, Inc. |
| 18260101 | NATURAL OIL-BASED COMPOSITION THAT MIMICS PETROLATUM AND METHOD OF MAKING SAME | Final Rejection | CARGILL, INCORPORATED |
| 17927550 | CERIUM OXIDE NANOPARTICLE, DISPERSION SOLUTION CONTAINING CERIUM OXIDE NANOPARTICLE, OXIDANT, ANTIVIRUS AGENT, AND ANTIBACTERIAL AGENT | Non-Final OA | Toray Industries, Inc. |
| 17757055 | DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASE | Final Rejection | Evonik Operations GmbH |
| 17792968 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | Final Rejection | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 17907595 | SKIN TREATMENT METHOD | Non-Final OA | Kao Corporation |
| 18042509 | ULTRAVIOLET-ABSORPTIVE NANOPARTICLES AND MICROPARTICLES FOR INTRADERMAL USE | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate |
| 18275622 | ACTIVE AGENT-RELEASING HYALURONIC ACID VEHICLE | Non-Final OA | Ariel Scientific Innovations Ltd. |
| 17996538 | SOLID DISPERSIONS AND PARTICLES AND METHODS FOR CONTROLLED-RELEASE OF LIPID-SOLUBLE OR DISPESIBLE ACTIVES | Final Rejection | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
| 18245399 | PYRETHROID IN-CAN ADJUVANTED SUSPENSION CONCENTRATES | Final Rejection | Bayer Aktiengesellschaft |
| 18282663 | CONCENTRATED COMPOSITION AND USES OF SAME | Non-Final OA | Johnson & Johnson Consumer Inc. |
| 18704112 | METHODS OF IMPLANTING ENGINEERED TISSUE CONSTRUCTS | Non-Final OA | Satellite Biosciences, Inc. |
| 18041300 | SANITIZER COMPOSITION IN EMULSION FORMULATION | Non-Final OA | Amorepacific Corporation |
| 18260297 | A SYNERGISTIC PERFUMING COMPOSITION | Non-Final OA | Firmenich SA |
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | Final Rejection | FMC CORPORATION |
| 17782734 | NEW PROCESS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | Final Rejection | NANEXA AB |
| 18016696 | Agrochemical mixtures of diamides, plant health additives and insecticide | Final Rejection | RAJDHANI PETROCHEMICALS PRIVATE LIMITED |
| 17602356 | PROCESS FOR CONTINUOUS PRODUCTION OF AN ACTIVE INGREDIENT GRANULATE | Final Rejection | ADD Advanced Drug Delivery Technologies Ltd. |
| 17824237 | SOLID DISPERSION OF PAN-RAF KINASE INHIBITOR | Non-Final OA | DAY ONE BIOPHARMACEUTICALS, INC. |
| 18223632 | METHODS AND COMPOSITIONS OF A LIQUID CONTROLLED-RELEASE PESTICIDE FOR TARGETED DELIVERY AND DRIFT REDUCTION | Final Rejection | SePRO Corporation |
| 17777415 | NEW COMPOSITIONS OF SUCRALFATE IN ALGINATE AND THEIR USE IN THERAPY | Final Rejection | NYUMA PHARMA SRL |
| 18248044 | GELMA POLYMER COMPOSITIONS AND USES THEREOF | Final Rejection | GELMEDIX, INC. |
| 17975759 | SYSTEM AND METHOD FOR TREATING HARVESTED PLANT MATERIAL WITH OZONE | Final Rejection | WillowPure, LLC |
| 17758215 | ORAL DISSOLVABLE FILM AND METHOD OF MANUFACTURING AND USING THE SAME | Final Rejection | CURE PHARMACEUTICAL HOLDING CORP. |
| 17776691 | LONG ACTING NMDA ANTAGONISTS | Final Rejection | Consegna Pharma, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy